Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.

Advances in anatomic pathology - 1 Sept 2018

Nguyen Jane Kim, Magi-Galluzzi Cristina

Abstract excerpt

Prostate cancer management has traditionally relied upon risk stratification of patients based on Gleason score, pretreatment prostate-specific antigen and clinical tumor stage. However, these factors alone do not adequately reflect the inherent complexity and heterogeneity of prostate cancer. Accurate and individualized risk stratification at the time of diagnosis is instrumental to facilitate clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Clinical Decision-Making
Share to Molecular Diagnostic Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 29727322
DOI: 10.1097/PAP.0000000000000192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.PMID 29727322Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier.Semantic proximity Read ↗

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the ProstateSemantic proximity Read ↗

GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform ArchitectureSemantic proximity Read ↗

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumorsSemantic proximity Read ↗

A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.Semantic proximity Read ↗

Temporal changes in the pathologic assessment of prostate cancer.Semantic proximity Read ↗

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterationsSemantic proximity Read ↗

Tissue-Based Biomarkers in Aggressive Variant Prostate Cancer: A Narrative ReviewSemantic proximity Read ↗

Clinical variability and molecular heterogeneity in prostate cancerSemantic proximity Read ↗

Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.